AKT1 and breast carcinoma: Along those lines, mTOR signaling that interferes with breast cancer growth has been shown to be the target of miR-99a [100], whereas miR-122 plays an important role in inhibiting tumorigenesis through targeting IGF1R and regulating the PI3K/Akt/mTOR/p70S6K pathway [101].